BNET Industries
Market Cap:$18.2M
Last Fiscal Year Sales:$293.0K
- Public
- US
Dow Jones Description
VaxGen is a biopharmaceutical company based in South San Francisco, California. The company owns a state-of-the-art biopharmaceutical manufacturing facility with a 1,000-liter bioreactor that can be used to make cell culture or microbial biologic products. Learn more...
Number of Employees 3
Contact Information
349 Oyster Point Blvd Ste 200
South San Francisco, California 94080
(650) 624-1000
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
OXiGENE Reports Third Quarter 2009 Financial Results
-
Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&D President;...
-
OXiGENE to Acquire VaxGen in a Stock-for-Stock Merger
-
OXiGENE To Buy VaxGen In A Stock-for-Stock Merger - Quick Facts
-
Skymark Research Initiates Independent Research Coverage On VaxGen, Inc.
News & Analysis
Filter by
investment and vaxgen inc. - All News and Analysis
Issues Pre-Market Stock Alerts for Thursday! January 25, 2007.
M2 PRESSWIRE-25 January 2007-Wall Street Capital Funding LLC: Issues Pre-Market Stock Alerts for Thursday! January 25, 2007C1994-2007 M2 COMMUNICATIONS LTD RDATE:25012007 Weston, FLA. - Wall Street News Alert's "stocks to watch" this morning are: ER Urgent Care Centers (OTC: ERUG), ...
Market news & up-trend stocks: GZFX, SUNW, LVLT, VXGN.
M2 PRESSWIRE-8 January 2007-TradersWorks.com: Market news & up-trend stocks: GZFX, SUNW, LVLT, VXGNC1994-2007 M2 COMMUNICATIONS LTD RDATE:08012007 Dallas, Texas -- TraderWorks.com reports news and movements on GameZnFlix, Inc. (OTCBB: GZFX), Sun Microsystems, Inc. (Nasdaq: SUNW), Level 3 Communications Inc (Nasdaq:...
ECMV, TOMO, TOPT, VXGN, CIGI, CTBG Have Been Added To Naked Short List Today.
M2 PRESSWIRE-22 May 2006-BUYINS.NET: ECMV, TOMO, TOPT, VXGN, CIGI, CTBG Have Been Added To Naked Short List TodayC1994-2006 M2 COMMUNICATIONS LTD RDATE:22052006 www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold...
VaxGen, Inc. Announces Initial Public Offering of 3,100,000 Shares of Common Stock
BRISBANE, Calif.--BUSINESS WIRE--June 30, 1999-- VaxGen, Inc. (Nasdaq:VXGN) announced today the initial public offering of 3,100,000 primary shares of its common stock at a price of $13.00 per share. VaxGen is developing preventive vaccines for worldwide use against HIV. VaxGen is currently conducting two large-scale Phase III clinical...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes



